[144] CME GROUP INC. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for CME Group Inc. (CME) shows a proposed sale of 392 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $102,704.00 and an approximate sale date of 09/18/2025 on NASDAQ. The securities were acquired from the issuer as restricted stock on 09/16/2025 and payment was recorded as 09/16/2025. The filing also reports prior transactions: the person for whose account the sale is filed sold 376 shares on 09/16/2025 for gross proceeds of $97,368.96. The filing includes the required representation that the signer does not possess undisclosed material adverse information.

Insights

Securities Analyst

TL;DR Insignificant insider sales disclosed; routine Rule 144 compliance.

The filing documents a proposed sale of 392 restricted shares shortly after acquisition and discloses a recent sale of 376 shares generating $97,368.96. Relative to the reported 360,377,042 shares outstanding, these amounts are immaterial and unlikely to affect market valuation. The filing meets Rule 144 disclosure requirements and includes the standard representation about absence of undisclosed material information. No earnings, debt, or material corporate actions are disclosed in this form.

Corporate Governance Expert

TL;DR Proper insider reporting; transaction size is de minimis versus outstanding shares.

This Form 144 appears to be a routine disclosure of proposed and recent insider sales tied to restricted stock granted by the issuer. The timing—acquisition on 09/16/2025 and proposed sale on 09/18/2025—indicates a rapid disposition subject to Rule 144 conditions. The form includes the required attestations and broker information, which supports transparency and regulatory compliance. From a governance perspective, no material governance or control changes are indicated.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	392	102704.00	360377042	09/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2025	Restricted Stock	ISSUER			392	09/16/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JONATHAN MARCUS 20 South Wacker Drive Chicago IL 60606	Common	09/16/2025	376	97368.96

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CME (CME) Form 144 disclose?

The form discloses a proposed sale of 392 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $102,704.00, and a reported sale of 376 shares on 09/16/2025 for $97,368.96.

When were the securities acquired that are proposed for sale?

The securities were acquired as restricted stock on 09/16/2025 from the issuer, with payment recorded the same day.

On which exchange are the proposed shares to be sold?

The proposed sale is to occur on NASDAQ with an approximate sale date of 09/18/2025.

Who is the broker handling the proposed sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

How large are these transactions relative to outstanding shares?

The filing reports 360,377,042 shares outstanding; the proposed sale of 392 shares is a de minimis portion of the outstanding shares.